刚果将获得7万剂Ervebo埃博拉疫苗，以应对当前由Bundibugyo病毒引发的疫情1。根据疫苗分配方案，其中2万剂将用于第三阶段临床试验，5万剂将配给一线卫生工作者1。
这场疫情形势严峻。截至报道时，该疫情已造成2,476人死亡，确诊病例数达5,208例1。死亡率达47.5%，其中北基伍省的死亡率更是高达70%1。当局于5月15日宣布疫情，但专家认为病毒早在2月就已开始在矿业城镇蒙布瓦卢传播1。这场疫情的传播速度约为2014至2016年西非疫情的三倍1。
WHO总干事特德罗斯·阿达诺姆·盖布雷耶苏斯将此举称为"全球团结的重要例证"1。
The Democratic Republic of Congo will receive 70,000 doses of Ervebo Ebola vaccine to combat an ongoing outbreak driven by the Bundibugyo virus 1. Of these doses, 20,000 will be allocated to phase three clinical trials while 50,000 will be distributed to frontline health workers 1.
The current outbreak has proven particularly severe, with 2,476 deaths among 5,208 confirmed cases, representing a 47.5 percent fatality rate—reaching as high as 70 percent in North Kivu province 1. The virus has spread at approximately three times the speed of the 2014-2016 West African epidemic, though authorities did not announce the outbreak until May 15, with experts believing transmission began as early as February in the mining town of Mbumbuvu 1. WHO Director-General Tedros Adhanom Ghebreyesus characterized the vaccine delivery as "an important demonstration of global solidarity" 1.
评论
还没有评论，欢迎留下第一条。